AQP4 and myeloid sarcoma: The closely similar disorder NMO (neuromyelitis optica), which was formerly included in the MS spectrum, is now recognized as a distinct entity due to the discovery that the target antigen of the antibody is the water channel anti-Aquaporin 4 (AQP4).